Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine or Hydroxychloroquine in COVID-19 Pneumonia
NCT04420247Phase 3Completed
- Sponsor
- CEPETI
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chloroquine, hydroxychloroquine in COVID-19 pneumonia, sponsored by CEPETI. Started Apr 2020; status: completed.
02
Drugs
chloroquinehydroxychloroquine
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04420247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420247.